PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20206692-5 2010 Interestingly, nuclear factor-kappaB (NF-kappaB) signaling, which is critical for 1,25-VD/VDR activity was found reduced in LNCaP-R cells, thereby treatment with NF-kappaB activator, 12-O-tetradecanoylphorbol-13-acetate (TPA), can sensitize LNCaP-R vitamin D response. Tetradecanoylphorbol Acetate 183-219 vitamin D receptor Homo sapiens 90-93 22871965-1 2012 Phorbol 12-myristate 13-acetate (PMA) increased 1,25(OH)(2)D(3)-induced human 25 hydroxyvitamin d-24 hydroxylase (hCYP24A1) gene expression and vitamin D receptor (VDR) binding to the hCYP24A1 promoter. Tetradecanoylphorbol Acetate 0-31 vitamin D receptor Homo sapiens 144-162 22871965-1 2012 Phorbol 12-myristate 13-acetate (PMA) increased 1,25(OH)(2)D(3)-induced human 25 hydroxyvitamin d-24 hydroxylase (hCYP24A1) gene expression and vitamin D receptor (VDR) binding to the hCYP24A1 promoter. Tetradecanoylphorbol Acetate 0-31 vitamin D receptor Homo sapiens 164-167 22871965-1 2012 Phorbol 12-myristate 13-acetate (PMA) increased 1,25(OH)(2)D(3)-induced human 25 hydroxyvitamin d-24 hydroxylase (hCYP24A1) gene expression and vitamin D receptor (VDR) binding to the hCYP24A1 promoter. Tetradecanoylphorbol Acetate 33-36 vitamin D receptor Homo sapiens 144-162 22871965-1 2012 Phorbol 12-myristate 13-acetate (PMA) increased 1,25(OH)(2)D(3)-induced human 25 hydroxyvitamin d-24 hydroxylase (hCYP24A1) gene expression and vitamin D receptor (VDR) binding to the hCYP24A1 promoter. Tetradecanoylphorbol Acetate 33-36 vitamin D receptor Homo sapiens 164-167 20206692-5 2010 Interestingly, nuclear factor-kappaB (NF-kappaB) signaling, which is critical for 1,25-VD/VDR activity was found reduced in LNCaP-R cells, thereby treatment with NF-kappaB activator, 12-O-tetradecanoylphorbol-13-acetate (TPA), can sensitize LNCaP-R vitamin D response. Tetradecanoylphorbol Acetate 221-224 vitamin D receptor Homo sapiens 90-93 11504768-11 2001 In combination with TPA, carnosic acid potentiated the expression of VDR and RAR-alpha. Tetradecanoylphorbol Acetate 20-23 vitamin D receptor Homo sapiens 69-72 20107497-5 2010 Human platelets and their TPA-differentiated precursors expressed a classical 50 kDa VDR protein, which increased with megakaryocytes maturation. Tetradecanoylphorbol Acetate 26-29 vitamin D receptor Homo sapiens 85-88 10460017-8 1999 The present study suggested that the activation of early c-fos response gene by TPA might be another mechanism to enhance the effect of 1,25-(OH)2D3, besides up-regulation of VDR. Tetradecanoylphorbol Acetate 80-83 vitamin D receptor Homo sapiens 175-178 10692108-6 2000 Interferon-gamma and the phorbolester 12-O-tetradecanoyl phorbol 13-acetate, two well-known inducers of keratinocyte differentiation, both inhibited vitamin D receptor expression but only interferon-gamma induced retinoid X receptor alpha. Tetradecanoylphorbol Acetate 38-75 vitamin D receptor Homo sapiens 149-167 10692108-7 2000 The decreased vitamin D receptor expression was accompanied by reduced vitamin D responsiveness (as assessed by 24-hydroxylase mRNA induction) in postconfluent, high calcium, and 12-O-tetradecanoyl phorbol 13-acetate treated keratinocytes but not with interferon-gamma treatment. Tetradecanoylphorbol Acetate 179-216 vitamin D receptor Homo sapiens 14-32 10460017-3 1999 It is interesting that TPA induced 24-hydroxylation activity far more efficiently than dbcAMP, in addition to their effects in increasing VDR. Tetradecanoylphorbol Acetate 23-26 vitamin D receptor Homo sapiens 138-141 9744516-1 1998 The effects of three inducers of differentiation, phorbol myristate acetate (PMA), retinoic acid (RA) and interferon-gamma (IFN-gamma), on the temporal regulation of vitamin D receptor (VDR) expression in HL-60 cells were analyzed by Northern blotting and immunofluorescence assays. Tetradecanoylphorbol Acetate 50-75 vitamin D receptor Homo sapiens 166-184 9744516-1 1998 The effects of three inducers of differentiation, phorbol myristate acetate (PMA), retinoic acid (RA) and interferon-gamma (IFN-gamma), on the temporal regulation of vitamin D receptor (VDR) expression in HL-60 cells were analyzed by Northern blotting and immunofluorescence assays. Tetradecanoylphorbol Acetate 50-75 vitamin D receptor Homo sapiens 186-189 9744516-1 1998 The effects of three inducers of differentiation, phorbol myristate acetate (PMA), retinoic acid (RA) and interferon-gamma (IFN-gamma), on the temporal regulation of vitamin D receptor (VDR) expression in HL-60 cells were analyzed by Northern blotting and immunofluorescence assays. Tetradecanoylphorbol Acetate 77-80 vitamin D receptor Homo sapiens 166-184 9348195-4 1997 Both 1,25-(OH)2D3 and TPA independently up-regulated the vitamin D receptor, p21, and the hypophosphorylated form of retinoblastoma (Rb) protein. Tetradecanoylphorbol Acetate 22-25 vitamin D receptor Homo sapiens 57-75 1656468-4 1991 Furthermore, when transfected CV-1 cells were treated with phorbol 12-myristate 13-acetate, a PKC activator, phosphorylation of wild-type hVDR was enhanced, whereas that of the Ser-51 mutant hVDR was unaffected. Tetradecanoylphorbol Acetate 59-90 vitamin D receptor Homo sapiens 138-142 1656468-4 1991 Furthermore, when transfected CV-1 cells were treated with phorbol 12-myristate 13-acetate, a PKC activator, phosphorylation of wild-type hVDR was enhanced, whereas that of the Ser-51 mutant hVDR was unaffected. Tetradecanoylphorbol Acetate 59-90 vitamin D receptor Homo sapiens 191-195